10.17

0.05% -0.005

Drugs Made In America Acquisition Ii Corp (DMII)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$10.16

Offen:

$10.21

24-Stunden-Volumen:

100

Relative Volume:

0.00

Marktkapitalisierung:

$650.38M

Einnahmen:

Nettoeinkommen (Verlust:

$8.58M

KGV:

75.90

EPS:

0.134

Netto-Cashflow:

$-1.11M

1W Leistung:

-0.10%

1M Leistung:

+0.49%

6M Leistung:

+2.21%

1J Leistung:

+0.00%

1-Tages-Spanne:

$10.21

1-Wochen-Bereich:

$10.16

$10.21

52-Wochen-Spanne:

$9.87

$10.21

Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile

Firmenname

Drugs Made In America Acquisition Ii Corp

Sektor

Financial (5731)

Branche

Shell Companies (227)

Telefon

954-870-3104

Adresse

420 LEXINGTON AVENUE, NEW YORK

Mitarbeiter

Twitter

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

DMII's Discussions on Twitter

Compare DMII vs LION, XXI, UMAC, CCXI

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DMII Drugs Made In America Acquisition Ii Corp	10.21	647.51M	0	8.58M	-1.11M	0.134
LION Lionsgate Studios Corp	11.07	3.32B	2.63B	-175.60M	11.40M	-0.7173
XXI Twenty One Capital Inc	5.765	3.30B	0	4.35M	456.40K	0.3397
UMAC Unusual Machines Inc	24.86	1.30B	17.25M	-5.64M	-40.16M	-0.3337
CCXI Churchill Capital Corp Xi	13.53	757.52M	0	0	0	0.0647

Drugs Made In America Acquisition Ii Corp Aktie (DMII) Neueste Nachrichten

Sep 08, 2026

Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times

Sep 08, 2026

Sep 07, 2026

Layoff Tracker: TScan axes 75% of workforce, prioritizes solid tumor program - BioSpace

Sep 07, 2026

Sep 06, 2026

Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Britannica

Sep 06, 2026

Sep 02, 2026

Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et

Sep 02, 2026

Sep 01, 2026

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® - PR Newswire

Sep 01, 2026

Aug 31, 2026

Pfizer Inc. - Britannica

Aug 31, 2026

Aug 25, 2026

Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat

Aug 25, 2026

Aug 22, 2026

Drugs (DMIIU) Momentum: Ends Little Changed at $10.20 in the Latest Reading; Immediate View: the Supplied Trading Band Runs From $9.69 to $10.71 under the Current SnapshotMomentum Breakout Ideas - siam.in

Aug 22, 2026

Aug 20, 2026

Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn

Aug 20, 2026

Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn

Aug 20, 2026

Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io

Aug 20, 2026

Aug 18, 2026

Drugs (DMIIR) Daily Review: Closes with Little Net Change at $0.10 in Latest Trading; Level-Based View: the Current Price Sits Inside the Supplied Technical Range at the CloseMerger Arbitrage - Vinanet

Aug 18, 2026

Aug 16, 2026

DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et

Aug 16, 2026

Aug 14, 2026

Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat

Aug 14, 2026

DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn

Aug 14, 2026

Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan

Aug 14, 2026

Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan

Aug 14, 2026

Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan

Aug 14, 2026

DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn

Aug 14, 2026